[Federal Register Volume 88, Number 248 (Thursday, December 28, 2023)]
[Notices]
[Page 89696]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-28614]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--CE24-013, Research Grants To Identify Effective 
Community-Based Strategies for Overdose Prevention (R01); Amended 
Notice of Closed Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--CE24-013, Research Grants to Identify Effective Community-Based 
Strategies for Overdose Prevention (R01); March 12-13, 2024, 8:30 a.m.-
5 p.m., EDT, web conference, in the original Federal Register notice. 
The meeting notice was published in the Federal Register on October 18, 
2023, Volume 88, Number 200, page 71867.
    The notice is being amended to change the meeting dates to a three-
day meeting. The notice should read as follows:
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)--CE24-013, Research Grants to 
Identify Effective Community-Based Strategies for Overdose Prevention 
(R01).
    Dates: March 12-14, 2024.
    Times: 8:30 a.m.-5 p.m., EDT.
    The meeting is closed to the public.

FOR FURTHER INFORMATION CONTACT: Aisha L. Wilkes, M.P.H., Scientific 
Review Officer, National Center for Injury Prevention and Control, 
Centers for Disease Control and Prevention, 4770 Buford Highway NE, 
Mailstop S106-9, Atlanta, Georgia 30341. Telephone: (404) 639-6473; 
Email: [email protected].
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-28614 Filed 12-27-23; 8:45 am]
BILLING CODE 4163-18-P